News Sentiment

NX1 sentiment intelligence

Nexalis Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 10 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.01 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

92/100 classification confidence.

Company focus 10

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, -50.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Nexalis Therapeutics Director Options Lapse Without Share Changes

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 92/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive -50.0% over four weeks
Fair value -67.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 10
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 10
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 6
TipRanks 3
grafa.com 1

Event Lens

What the news is about

Classified themes
Market update 9
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-10 of 10